News

China vape export VAT rebate cancellation 2026
Vape industry after Chinese New Year 2026
Vape hardware price increase 2026
China vape tax policy impact
How U.S. buyers should prepare for vape cost changes in Q2 2026

2026 vape pricing reset
vape hardware pricing 2026
vape supplier risk 2026
U.S. vape buyer strategy

why vape hardware prices are rising in 2026
impact of battery rebate cuts on vape devices
China export VAT policy vape hardware
vape battery cost structure explained
multi-layer cost increase vape manufacturing

China vape export VAT rebate
China vape VAT rebate cancellation
China vape VAT policy 2026
vape export VAT China
China vape tax policy

Vape hardware prices are rising in 2026 due to China's VAT rebate cancellation and higher material costs.

Learn why this is an industry-wide cost reset, not a supplier decision.

China export VAT rebate cancellation
vape export VAT 2026
China vape tax policy
vape hardware cost increase
vape pricing impact 2026
battery VAT rebate adjustment

How does China VAT rebate cancellation affect vape prices
Will vape hardware prices increase in 2026
Can empty vape hardware avoid China VAT
Why vape prices are increasing in China
How China VAT policy affects U.S. vape buyers

Ceramic coils represent a significant development in vaping, not only due to their clean flavor production but also because they pose fewer health risks. Unlike low-quality cartridges utilizing metal coils with cotton-wicking agents, ceramic coils eliminate concerns about chemicals leaching from the material. Furthermore, the absence of pre-moistened wicks, often primed with glycerin or propylene glycol, minimizes the risk of allergic reactions.

The marijuana industry in the United States has been rapidly growing in recent years, driven by changing attitudes towards cannabis and its legalization for both medical and recreational use in many states. This industry encompasses various aspects, including cultivation, processing, distribution, and sales of marijuana products.

The DEA is planning to reclassify marijuana from a Schedule I to a Schedule III controlled substance. The shift, which would still require ultimate approval from the White House, could broaden access to use marijuana in the United States and may ease restrictions to conduct research on the drug，which could have a profound impact on US drug policy.